Histone acetyltransferase lysine acetyltransferase 2A (LAT2A) enhances tamoxifen drug resistance during the treatment course of breast cancer by decreasing p53 stability and increasing breast cancer 1 (AIB1) expression [36]. Here, TP53 is linked to breast carcinoma.